Related Experiment Video
Updated: Aug 18, 2026
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Apo-dystrophin-3: a 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site
J M Tinsley1, D J Blake, K E Davies
1Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK.
Abstract:
The molecular defect in Duchenne muscular dystrophy is well established as being due to mutations at Xp21 which disrupt the normal synthesis of the 14kb dystrophin mRNA. More recently, several groups have identified a 4.8kb transcript from this locus which shares exons with the carboxy-terminal region of the dystrophin gene. In this paper we present evidence for an additional 2.2kb mRNA transcript. The 5' untranslated region and first 7 amino acids are identical to that published for the 4.8kb transcript. The position of the translational stop codon and 3' untranslated region is similar to that previously described as the truncated fetal dystrophin isoform. This 2.2kb mRNA has a similar tissue distribution to that described for the 4.8kb mRNA but unlike the other transcripts from the DMD locus, the 2.2kb mRNA is expressed in early development. The relevance of this transcript in the clinical expression of muscular dystrophy and developmental delay is discussed.
Insights
Researchers discovered a new 2.2kb dystrophin mRNA transcript in Duchenne muscular dystrophy (DMD) research. This transcript is expressed during early development, offering new insights into DMD and developmental delay.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Duchenne muscular dystrophy (DMD) is linked to mutations at Xp21, affecting dystrophin mRNA synthesis.
- Previously identified transcripts include a 14kb mRNA and a 4.8kb transcript sharing exons with the dystrophin gene.
Purpose of the Study:
- To identify and characterize novel mRNA transcripts associated with the Duchenne muscular dystrophy locus.
- To investigate the expression patterns and potential clinical relevance of a newly identified 2.2kb mRNA transcript.
Main Methods:
- Analysis of mRNA transcripts from the DMD locus.
- Comparison of sequence identity and expression patterns of different dystrophin-related transcripts.
- Investigation of tissue distribution and developmental expression profiles.
Main Results:
- Identification of a novel 2.2kb mRNA transcript originating from the DMD locus.
- The 2.2kb transcript shares sequence features with the 4.8kb transcript and a truncated fetal dystrophin isoform.
- Unlike other DMD transcripts, the 2.2kb mRNA is expressed during early development and shows similar tissue distribution to the 4.8kb mRNA.
Conclusions:
- The discovery of the 2.2kb mRNA transcript expands our understanding of dystrophin gene expression.
- Its unique early developmental expression suggests a potential role in clinical manifestations of Duchenne muscular dystrophy and developmental delay.
- Further research is warranted to elucidate the functional significance of this transcript.
